Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections

Keer Sun, Jianqiang Ye, Daniel R. Perez, Dennis W. Metzger

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

T cell epitopes have been found to be shared by circulating, seasonal influenza virus strains and the novel pandemic H1N1 influenza infection, but the ability of these common epitopes to provide cross-protection is unknown. We have now directly tested this by examining the ability of live seasonal influenza vaccine (FluMist) to mediate protection against swine-origin H1N1 influenza virus infection. Naive mice demonstrated considerable susceptibility to H1N1 Cal/04/09 infection, whereas FluMist-vaccinated mice had markedly decreased morbidity and mortality. In vivo depletion of CD4+ or CD8+ immune cells after vaccination indicated that protective immunity was primarily dependent upon FluMist-induced CD4+ cells but not CD8+ T cells. Passive protection studies revealed little role for serum or mucosal Abs in cross-protection. Although H1N1 influenza infection of naive mice induced intensive phagocyte recruitment, pulmonary innate defense against secondary pneumococcal infection was severely suppressed. This increased susceptibility to bacterial infection was correlated with augmented IFN-γ production produced during the recovery stage of H1N1 influenza infection, which was completely suppressed in mice previously immunized with FluMist. Furthermore, susceptibility to secondary bacterial infection was decreased in the absence of type II, but not type I, IFN signaling. Thus, seasonal FluMist treatment not only promoted resistance to pandemic H1N1 influenza infection but also restored innate immunity against complicating secondary bacterial infections.

Original languageEnglish (US)
Pages (from-to)987-993
Number of pages7
JournalJournal of Immunology
Volume186
Issue number2
DOIs
StatePublished - Jan 15 2011

Fingerprint

Influenza Vaccines
Coinfection
Bacterial Infections
Human Influenza
Immunity
Vaccination
T-Lymphocytes
Cross Protection
Infection
Pandemics
Orthomyxoviridae
Pneumococcal Infections
H1N1 Subtype Influenza A Virus
T-Lymphocyte Epitopes
Virus Diseases
Phagocytes
Innate Immunity
Epitopes
Swine
Morbidity

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections. / Sun, Keer; Ye, Jianqiang; Perez, Daniel R.; Metzger, Dennis W.

In: Journal of Immunology, Vol. 186, No. 2, 15.01.2011, p. 987-993.

Research output: Contribution to journalArticle

@article{4e47495035744dcca2195850415d47c5,
title = "Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections",
abstract = "T cell epitopes have been found to be shared by circulating, seasonal influenza virus strains and the novel pandemic H1N1 influenza infection, but the ability of these common epitopes to provide cross-protection is unknown. We have now directly tested this by examining the ability of live seasonal influenza vaccine (FluMist) to mediate protection against swine-origin H1N1 influenza virus infection. Naive mice demonstrated considerable susceptibility to H1N1 Cal/04/09 infection, whereas FluMist-vaccinated mice had markedly decreased morbidity and mortality. In vivo depletion of CD4+ or CD8+ immune cells after vaccination indicated that protective immunity was primarily dependent upon FluMist-induced CD4+ cells but not CD8+ T cells. Passive protection studies revealed little role for serum or mucosal Abs in cross-protection. Although H1N1 influenza infection of naive mice induced intensive phagocyte recruitment, pulmonary innate defense against secondary pneumococcal infection was severely suppressed. This increased susceptibility to bacterial infection was correlated with augmented IFN-γ production produced during the recovery stage of H1N1 influenza infection, which was completely suppressed in mice previously immunized with FluMist. Furthermore, susceptibility to secondary bacterial infection was decreased in the absence of type II, but not type I, IFN signaling. Thus, seasonal FluMist treatment not only promoted resistance to pandemic H1N1 influenza infection but also restored innate immunity against complicating secondary bacterial infections.",
author = "Keer Sun and Jianqiang Ye and Perez, {Daniel R.} and Metzger, {Dennis W.}",
year = "2011",
month = "1",
day = "15",
doi = "10.4049/jimmunol.1002664",
language = "English (US)",
volume = "186",
pages = "987--993",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections

AU - Sun, Keer

AU - Ye, Jianqiang

AU - Perez, Daniel R.

AU - Metzger, Dennis W.

PY - 2011/1/15

Y1 - 2011/1/15

N2 - T cell epitopes have been found to be shared by circulating, seasonal influenza virus strains and the novel pandemic H1N1 influenza infection, but the ability of these common epitopes to provide cross-protection is unknown. We have now directly tested this by examining the ability of live seasonal influenza vaccine (FluMist) to mediate protection against swine-origin H1N1 influenza virus infection. Naive mice demonstrated considerable susceptibility to H1N1 Cal/04/09 infection, whereas FluMist-vaccinated mice had markedly decreased morbidity and mortality. In vivo depletion of CD4+ or CD8+ immune cells after vaccination indicated that protective immunity was primarily dependent upon FluMist-induced CD4+ cells but not CD8+ T cells. Passive protection studies revealed little role for serum or mucosal Abs in cross-protection. Although H1N1 influenza infection of naive mice induced intensive phagocyte recruitment, pulmonary innate defense against secondary pneumococcal infection was severely suppressed. This increased susceptibility to bacterial infection was correlated with augmented IFN-γ production produced during the recovery stage of H1N1 influenza infection, which was completely suppressed in mice previously immunized with FluMist. Furthermore, susceptibility to secondary bacterial infection was decreased in the absence of type II, but not type I, IFN signaling. Thus, seasonal FluMist treatment not only promoted resistance to pandemic H1N1 influenza infection but also restored innate immunity against complicating secondary bacterial infections.

AB - T cell epitopes have been found to be shared by circulating, seasonal influenza virus strains and the novel pandemic H1N1 influenza infection, but the ability of these common epitopes to provide cross-protection is unknown. We have now directly tested this by examining the ability of live seasonal influenza vaccine (FluMist) to mediate protection against swine-origin H1N1 influenza virus infection. Naive mice demonstrated considerable susceptibility to H1N1 Cal/04/09 infection, whereas FluMist-vaccinated mice had markedly decreased morbidity and mortality. In vivo depletion of CD4+ or CD8+ immune cells after vaccination indicated that protective immunity was primarily dependent upon FluMist-induced CD4+ cells but not CD8+ T cells. Passive protection studies revealed little role for serum or mucosal Abs in cross-protection. Although H1N1 influenza infection of naive mice induced intensive phagocyte recruitment, pulmonary innate defense against secondary pneumococcal infection was severely suppressed. This increased susceptibility to bacterial infection was correlated with augmented IFN-γ production produced during the recovery stage of H1N1 influenza infection, which was completely suppressed in mice previously immunized with FluMist. Furthermore, susceptibility to secondary bacterial infection was decreased in the absence of type II, but not type I, IFN signaling. Thus, seasonal FluMist treatment not only promoted resistance to pandemic H1N1 influenza infection but also restored innate immunity against complicating secondary bacterial infections.

UR - http://www.scopus.com/inward/record.url?scp=79251555970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251555970&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1002664

DO - 10.4049/jimmunol.1002664

M3 - Article

C2 - 21160043

AN - SCOPUS:79251555970

VL - 186

SP - 987

EP - 993

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -